178 related articles for article (PubMed ID: 10663386)
1. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
[TBL] [Abstract][Full Text] [Related]
2. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist.
Elmazar MM; Rühl R; Nau H
Toxicol Appl Pharmacol; 2001 Jan; 170(1):2-9. PubMed ID: 11141350
[TBL] [Abstract][Full Text] [Related]
3. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
5. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
6. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
[TBL] [Abstract][Full Text] [Related]
7. Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding protein.
Sass JO; Hartmann J; Chahoud I; Shroot B; Nau H
Toxicol Lett; 1995 Jan; 75(1-3):159-68. PubMed ID: 7863522
[TBL] [Abstract][Full Text] [Related]
8. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
9. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
Kochhar DM; Jiang H; Penner JD; Beard RL; ChandraratnaAS
Chem Biol Interact; 1996 Mar; 100(1):1-12. PubMed ID: 8599851
[TBL] [Abstract][Full Text] [Related]
10. The RARgamma selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis.
Jiang SY; Lin DY; Shyu RY; Reichert U; Yeh MY
Cancer Lett; 1999 Apr; 137(2):217-25. PubMed ID: 10374844
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells.
Boisvieux-Ulrich E; Le Pechon-Vallée C; Million K; Baeza-Squiban A; Houcine O; Guennou C; Reichert U; Marano F
Cell Tissue Res; 2000 Apr; 300(1):67-81. PubMed ID: 10805076
[TBL] [Abstract][Full Text] [Related]
12. Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein.
Willhite CC; Jurek A; Sharma RP; Dawson MI
Toxicol Appl Pharmacol; 1992 Jan; 112(1):144-53. PubMed ID: 1310166
[TBL] [Abstract][Full Text] [Related]
13. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
14. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
[TBL] [Abstract][Full Text] [Related]
15. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
[TBL] [Abstract][Full Text] [Related]
16. Teratology of retinoids.
Collins MD; Mao GE
Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
[TBL] [Abstract][Full Text] [Related]
17. The role of metabolism and toxicokinetics in retinoid teratogenesis.
Tzimas G; Nau H
Curr Pharm Des; 2001 Jun; 7(9):803-31. PubMed ID: 11375780
[TBL] [Abstract][Full Text] [Related]
18. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
19. The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells.
Von Schroeder HP; Hashimoto Y; Heersche JN
Teratology; 1994 Jul; 50(1):54-62. PubMed ID: 7974255
[TBL] [Abstract][Full Text] [Related]
20. RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways.
Elmazar MM; Rühl R; Reichert U; Shroot B; Nau H
Toxicol Appl Pharmacol; 1997 Sep; 146(1):21-8. PubMed ID: 9299593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
